Research paper
View All-
Kwanjoo Lee
Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: A multinational population-based cohort study from South Korea, Japan, and the UK
-
Yiyuan Zheng
Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease
-
Ming-Ying Lu
Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program
-
Young Eun Chon
Correspondence to editorial on “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study”
-
Do Seon Song
Correspondence to editorial on “Dynamic analysis of acute deterioration in chronic liver disease patients using modified quick sequential organ failure assessment”
-
Do Seon Song
Dynamic analysis of acute deterioration in chronic liver disease patients using modified quick sequential organ failure assessment
-
Junjie Yu
Macrophage ATG16L1: Potential candidate for metabolic dysfunction-associated steatohepatitis treatment: Editorial on “Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy”
-
Jia Liu
Current status and perspective on molecular targets and therapeutic intervention strategy in hepatic ischemia-reperfusion injury
-
Michael H. Le
Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis
-
Miguel Sogbe
Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment